AttoDx, Inc. is a biotechnology company developing applications for Molecular Viability Testing. The firm's primary technology, MVT, is an innovative method for detecting viable bacterial pathogens versus non-viable pathogens or residual nucleic acids that can lead to false positives. The technology aims to provide rapid and reliable testing for bacterial contamination for safety in food and water, controlling infectious diseases, manufacturing of pharmaceutical products, and medical diagnostics. MVT has been proven successful in distinguishing viable bacteria including gram negative, gram positive,anaerobic and aerobic bacteria species that are important in food safety, water quality, and patient health and safety.
